Susquehanna International Group, LLP Savara Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$3.96 - $5.07 $24,156 - $30,927	6,100 Added 29.33%	26,900 $114,000
Q2 2024 Aug 15, 2024	SELL	$3.66 - $5.34 $231,678 - $338,022	-63,300 Reduced 75.27%	20,800 $83,000
Q1 2024 May 07, 2024	BUY	$4.19 - $5.59 $179,751 - $239,811	42,900 Added 104.13%	84,100 $418,000
Q4 2023 Feb 14, 2024	SELL	$3.18 - $4.9 $64,236 - $98,980	-20,200 Reduced 32.9%	41,200 $193,000
Q3 2023 Nov 14, 2023	SELL	$2.97 - $3.88 $24,948 - $32,592	-8,400 Reduced 12.03%	61,400 $232,000
Q2 2023 Aug 11, 2023	SELL	$1.69 - $3.24 $33,124 - $63,504	-19,600 Reduced 21.92%	69,800 $222,000
Q1 2023 May 16, 2023	SELL	$1.6 - $2.82 $19,680 - $34,686	-12,300 Reduced 12.09%	89,400 $174,000
Q4 2022 Feb 14, 2023	SELL	$1.11 - $1.64 $29,748 - $43,952	-26,800 Reduced 20.86%	101,700 $157,000
Q3 2022 Nov 14, 2022	BUY	$1.36 - $1.88 $47,056 - $65,047	34,600 Added 36.85%	128,500 $199,000
Q2 2022 Aug 15, 2022	BUY	$1.1 - $1.58 $65,670 - $94,326	59,700 Added 174.56%	93,900 $143,000
Q1 2022 May 16, 2022	SELL	$1.05 - $1.36 $12,915 - $16,728	-12,300 Reduced 26.45%	34,200 $45,000
Q3 2021 Nov 15, 2021	SELL	$1.18 - $1.64 $52,864 - $73,472	-44,800 Reduced 49.07%	46,500 $64,000
Q2 2021 Aug 11, 2021	SELL	$1.51 - $2.29 $115,062 - $174,498	-76,200 Reduced 45.49%	91,300 $155,000
Q1 2021 May 17, 2021	BUY	$1.17 - $2.33 $177,021 - $352,529	151,300 Added 933.95%	167,500 $348,000
Q4 2020 Feb 16, 2021	SELL	$1.0 - $1.47 $7,800 - $11,466	-7,800 Reduced 32.5%	16,200 $19,000
Q3 2020 Nov 16, 2020	BUY	$1.09 - $2.21 $4,905 - $9,945	4,500 Added 23.08%	24,000 $26,000
Q2 2020 Aug 14, 2020	BUY	$1.8 - $3.05 $6,660 - $11,285	3,700 Added 23.42%	19,500 $49,000
Q1 2020 May 15, 2020	BUY	$1.91 - $4.08 $2,483 - $5,304	1,300 Added 8.97%	15,800 $33,000
Q4 2019 Feb 14, 2020	SELL	$0.71 - $4.91 $269,729 - $1.87 Million	-379,900 Reduced 96.32%	14,500 $65,000
Q2 2019 Aug 14, 2019	BUY	$2.37 - $11.7 $829,026 - $4.09 Million	349,800 Added 784.3%	394,400 $935,000
Q3 2018 Nov 14, 2018	BUY	$10.49 - $12.87 $7,343 - $9,009	700 Added 1.59%	44,600 $498,000
Q2 2018 Aug 14, 2018	BUY	$8.55 - $13.76 $218,880 - $352,256	25,600 Added 139.89%	43,900 $497,000
Q1 2018 May 15, 2018	BUY	$8.99 - $14.95 $164,517 - $273,585	18,300 New	18,300 $168,000

Others Institutions Holding SVRA

# of Institutions

133

Shares Held

149M

Call Options Held

67.6K

Put Options Held

29.4K

Nea Management Company, LLC Timonium, MD

24.5M
Shares

$67.3 Million
7.93% of portfolio
Bain Capital Life Sciences Investors, LLC Boston, MA

14.6M
Shares

$40.1 Million
11.08% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

12.4M
Shares

$34 Million
6.8% of portfolio
Vanguard Group Inc Valley Forge, PA

8.31M
Shares

$22.9 Million
0.0% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

8.16M
Shares

$22.4 Million
1.86% of portfolio

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $314M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account